With Preclinical Research Development, we help investigators gain access to the expertise and tools needed to prepare innovative ideas for human testing. We support and sustain novel technologies and methodologies through the early phases of development, when funding and expertise are most needed.
The overall goal of the Preclinical Research Development program is to accelerate new medical product development in the academic setting and to enhance the opportunities for their commercialization. In order to compete effectively for translational research dollars and position inventions for future investment, academic investigators must now be able to clearly articulate viable commercialization, clinical, and regulatory strategies for their products. In addition the investigator must assemble a nonclinical data package (e.g., pharmacology, pharmacokinetics, and product characterization), that will support the regulatory requirements for initiation of clinical trials.